Billings Clinic
Especially For:

Clinical Trials

Title   Breast: DCIS HER2+
Description   NSABP B-43 A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
IRB Number   NSABP B 43
Category   Breast
Inclusion/Notes   HER2 testing done by central lab, Performance Status 0-1, Mixed DCIS & LCIS is ok, Node - must be assessed.
Status   Active
Start Date   12/12/2008
Principal Investigator (PI)   Brock Whittenberger, MD
Contact Name   Tauna Jeffery
Contact Email
Phone   (406) 435-7484
Alternate Phone   (406) 255-8400
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.